Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
31
1
2
3
4
5
6
8
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
31
1
2
3
Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 37th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO [...]
Allergan to Present at the 37th Annual J.P. Morgan Healthcare Conference
2019-01-07    
3:30 pm
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, [...]
Johnson & Johnson to Participate in 37th Annual JP Morgan Health Care Conference
2019-01-07    
3:30 pm
Johnson & Johnson (NYSE: JNJ) will participate in the 37th Annual JP Morgan Health Care Conference on Monday, Jan. 7th, at the Westin St. Francis in San Francisco.  Joseph J. [...]
Halozyme Therapeutics To Present At The 37th Annual J.P. Morgan Healthcare Conference
2019-01-09    
10:30 am
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference in San [...]
International Conference on Chemistry, Chemical Engineering and Chemical Process
2019-01-30 - 2019-01-31    
All Day
It is a great pleasure and an honor to extend to you a warm invitation to attend the "International Conference on Chemistry, Chemical Engineering and [...]
Streamline HCP Workflow • Drive Patient Education • Navigate the Specialty Prescribing Landscape
2019-02-01    
12:00 am
The original and most comprehensive conference series dedicated entirely to strategies for effective utilization of e-Rx and EHR technologies is back for 2019. Whether new [...]
Latest News

Cerner’s HealtheIntent on a Roll: Wins a String of Contracts

amazing charts

Cerner Corporation (CERNAnalyst Report) continues to win important contracts for its population health management platform – HealtheIntent – which is expected to drive the company’s top line significantly.

HealtheIntent was recently picked by Broward Health which will help the latter’s systems come out with advanced clinical outcomes through superior analysis of patient health and access to a large data base.

Notably, HealtheIntent helps retrieve data from various sources, including Electronic Health Records (EHR) and Health Information Technology (HIT) systems, which in turn helps organizations understand and treat patients better.

Broward Health, which has been a Cerner Millennium client, will also deploy Cerner’s Readmission Prevention – a solution designed to forecast and recognize patients at readmission risks, ease processes across facilities and maintain an integrated workflow.

Digitization of healthcare information through EHRs is a vital step for the medical industry. However, the assimilation of data from EHR platforms and other external sources needs to be done for a more personalized treatment of patients. HealtheIntent intends to provide such a service to Broward Health and other such organizations who have adopted the platform.

In fact, HealtheIntent has been gaining contracts for quite some time now. In October, Geisinger Health System chose Cerner’s HealtheIntent population health management platform to further expand the former’s data-driven population health capabilities.

HealtheIntent, along with Cerner Millennium EHR, was also selected by McLaren Health Care for the implementation of EHR and population health management across their facilities in Michigan. Moreover, these platforms were selected by Western Connecticut Health Network in September and by Baptist Health South Florida in August.

Zacks Rank & Stocks to Consider

Currently, Cerner carries a Zacks Rank #4 (Sell). Better-ranked stocks in the medical sector are Masimo (MASIAnalyst Report), Natus Medical (BABYSnapshot Report) and Olympus Corp (OCPNYSnapshot Report). All three stocks sport a Zacks Rank #1 (Strong Buy).